Use of a Novel Adhesive Suture Retention Device in Non-traumatic Diabetic Lower Extremity Amputations: A Multicenter Case Review
- PMID: 37743966
- PMCID: PMC10517667
Use of a Novel Adhesive Suture Retention Device in Non-traumatic Diabetic Lower Extremity Amputations: A Multicenter Case Review
Abstract
Background: Amputations in the diabetic foot are commonly associated with complications, including delayed wound healing, surgical site dehiscence, and the need for additional amputations. Use of a novel adhesive suture retention device (ASRD) has been previously shown to support improved linear closure outcomes. The purpose of this retrospective case review was to determine if the adoption of the ASRD in 5 podiatric surgical practices would reduce postoperative complications in patients with diabetes undergoing foot amputations including surgical site dehiscence and the need for additional amputation.
Methods: A 5-center retrospective chart review was performed to assess the difference in postoperative surgical site dehiscence and reamputation rates for patients with diabetes undergoing minor and major lower extremity amputations before and after adopting the use of the ARSD.
Results: Adoption of the adhesive retention suture device was associated with an overall decrease in wound dehiscence of 81% (P < .01). Additionally, there was an 89% reduction in progression to higher level amputation in the ARSD cohort (P = .015).
Conclusions: Utilization of the ARSD decreased the incidence of postoperative wound dehiscence and reamputation in this patient cohort, thus lessening patient morbidity and decreasing the overall cost of care.
Keywords: Amputation; Dehiscence; Diabetes; Podiatrie Surgery.
© 2023 HMP Global. All Rights Reserved. Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of ePlasty or HMP Global, their employees, and affiliates.
Conflict of interest statement
Disclosures: Authors WC and EH are medical advisors for Suturegard. The authors declare no other conflicts of interest or financial disclosures.
Figures
References
-
- Sun H, Saeedi P, Karuranga S, Pinkepank M, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. doi:10.1016/j.diabres.2021.10911910.1016/j.diabres.2021.109119 - DOI - DOI - PMC - PubMed
-
- Trautner C, Haastert B, Spraul M, Giani G, Berger M. Unchanged incidence of lower-limb amputations in a German City, 1990-1998. Diabetes Care. 2001;24(5):855–859. doi:10.2337/diacare.24.5.85510.2337/diacare.24.5.855 - DOI - DOI - PubMed
-
- Almaraz MC, Gonzalez-Romero S, Bravo M, et al. Incidence of lower limb amputations in individuals with and without diabetes mellitus in Andalusia (Spain) from 1998 to 2006. Diabetes Res Clin Pract. 2012; 95(3):399–405. doi:10.1016/j.diabres.2011.10.03510.1016/j.diabres.2011.10.035 - DOI - DOI - PubMed
-
- Berendt AR, Peters EJ, Bakker K, et al. Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. Diabetes Metab Res Rev. 2008. May-Jun;24 Suppl 1:S145–S161. doi:10.1002/dmrr.83610.1002/dmrr.836 - DOI - DOI - PubMed
-
- Vassalo IM, Gatt A, Cassar K, Papanas N, Formosa C. Healing and mortality rates following toe amputation in type II diabetes mellitus. Exp Clin Endocrinol Diabetes. 2021;129(6:438–442. doi:10.1055/a-0942-178910.1055/a-0942-1789 - DOI - DOI - PubMed
LinkOut - more resources
Full Text Sources